|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash and due from banks | ||||||||||||
| Federal funds sold | ||||||||||||
| Total cash and cash equivalents | ||||||||||||
| Available-for-sale securities, at fair value | ||||||||||||
| Loans held for sale, at fair value | ||||||||||||
| Loans receivable, net of deferred fees | ||||||||||||
| Allowance for credit losses | ||||||||||||
| Net loans | ||||||||||||
| Accrued interest receivable | ||||||||||||
| Banking premises and equipment, net | ||||||||||||
| Depositors Insurance Fund stock | ||||||||||||
| Federal Home Loan Bank stock, at cost | ||||||||||||
| Federal Reserve Bank stock, at cost | ||||||||||||
| Non-public investments | ||||||||||||
| Bank-owned life insurance ("BOLI") | ||||||||||||
| Prepaid expenses and other assets | ||||||||||||
| Income tax refunds receivable | ||||||||||||
| Goodwill | ||||||||||||
| Core deposit intangible, net | ||||||||||||
| Deferred income tax asset, net | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and shareholders' equity | ||||||||||||
| Deposits | ||||||||||||
| Core deposits | ||||||||||||
| Brokered deposits | ||||||||||||
| Total deposits | ||||||||||||
| Mortgagors' escrow accounts | ||||||||||||
| Federal Home Loan Bank ("FHLB") borrowings | ||||||||||||
| Accrued expenses and other liabilities | ||||||||||||
| Accrued retirement liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Shareholders' equity: | ||||||||||||
| Preferred stock, $0.01 par value, 5,000,000 shares authorized; no shares issued and outstanding | ||||||||||||
| Common stock, $0.01 par value, 120,000,000 shares authorized; 43,818,490 and 45,770,128 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Unallocated common shares held by the Employee Stock Ownership Plan ("ESOP") | ||||||||||||
| Retained earnings | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Total shareholders' equity | ||||||||||||
| Total liabilities and shareholders' equity |
Loading...
